Please find below the links associated with yesterday’s Health Canada regulatory statement on AstraZeneca, NACI’s statement on the use of AstraZeneca, and the CCMOH Statement on the Use of AstraZeneca COVID-19 vaccine in younger adults. 

Health Canada Regulatory Statement on AstraZeneca:

EN: https://www.canada.ca/en/health-canada/news/2021/03/health-canada-taking-further-action-to-confirm-the-benefit-risk-profile-of-the-astrazeneca-vaccine.html

FR : https://www.canada.ca/fr/sante-canada/nouvelles/2021/03/sante-canada-prend-des-mesures-supplementaires-pour-confirmer-le-profil-avantages-risques-du-vaccin-dastrazeneca.html

NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults

EN: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommended-use-astrazeneca-covid-19-vaccine-younger-adults.html

FR : https://www.canada.ca/fr/sante-publique/services/immunisation/comite-consultatif-national-immunisation-ccni/reponse-rapide-recommandation-utilisation-vaccin-astrazeneca-covid-19-jeunes-adultes.html

Crosslinks added on the main NACI page:
EN: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci.html

FR : https://www.canada.ca/fr/sante-publique/services/immunisation/comite-consultatif-national-immunisation-ccni.html

CCMOH Statement on the use of AstraZeneca COVID-19 vaccine in younger adults:

EN: https://www.canada.ca/en/public-health/news/2021/03/use-of-astrazeneca-covid-19-vaccine.html

FR : https://www.canada.ca/fr/sante-publique/nouvelles/2021/03/utilisation-du-vaccin-astra-zeneca-contre-la-covid-19.html